Kristen Williams - Jan 18, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Signature
/s/ Kristen Williams
Stock symbol
PCRX
Transactions as of
Jan 18, 2022
Transactions value $
-$527,367
Form type
4
Date filed
1/20/2022, 06:24 PM
Previous filing
Jun 11, 2021
Next filing
Jan 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Options Exercise $60.8K +1.38K +6.17% $44.20 23.6K Jan 18, 2022 Direct F1
transaction PCRX Common Stock Options Exercise $99.7K +2.6K +11% $38.35 26.2K Jan 18, 2022 Direct F1
transaction PCRX Common Stock Options Exercise $276K +6.34K +24.15% $43.54 32.6K Jan 18, 2022 Direct F1
transaction PCRX Common Stock Options Exercise $626K +13.1K +40.29% $47.65 45.7K Jan 18, 2022 Direct F1
transaction PCRX Common Stock Sale -$1.5M -23K -50.41% $65.24 22.7K Jan 18, 2022 Direct F1, F2
transaction PCRX Common Stock Sale -$26.5K -400 -1.76% $66.14 22.3K Jan 18, 2022 Direct F1, F3
transaction PCRX Common Stock Options Exercise $84.3K +2.2K +9.88% $38.35 24.5K Jan 19, 2022 Direct F1
transaction PCRX Common Stock Sale -$144K -2.2K -8.99% $65.51 22.3K Jan 19, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -1.38K -100% $0.00* 0 Jan 18, 2022 Common Stock 1.38K $44.20 Direct F5
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -2.6K -17.61% $0.00 12.2K Jan 18, 2022 Common Stock 2.6K $38.35 Direct F6
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -6.34K -33.34% $0.00 12.7K Jan 18, 2022 Common Stock 6.34K $43.54 Direct F6
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -13.1K -37.51% $0.00 21.9K Jan 18, 2022 Common Stock 13.1K $47.65 Direct F6
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -2.2K -18.08% $0.00 9.97K Jan 19, 2022 Common Stock 2.2K $38.35 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.02 to $65.95, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.07 to $66.27, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.055 to $65.880, inclusive.
F5 The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.
F6 The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.